Table 4.
Correlations between the preoperative CEA levels and the site of recurrence in stage II rectal cancer and colon cancer
| Rectal Cancer CEA ( ng/ml) | Colon Cancer CEA ( ng/ml) | |||||
|---|---|---|---|---|---|---|
| CEA<5 | CEA ≥5 | p-Value | CEA <5 | CEA ≥5 | p-Value | |
| n = 191 | n = 170 | n = 389 | n = 219 | |||
| Liver metastasis | ||||||
| Negative | 187 (97.91%) | 161 (94.71%) | 381 (97.94%) | 209 (95.43%) | ||
| Positive | 4 (2.09%) | 9 (5.29%) | 0.10 | 8 (2.06%) | 10 (4.57%) | 0.07 |
| Lung metastasis | ||||||
| Negative | 187 (97.91%) | 163 (95.88%) | 384 (98.71%) | 214 (97.72%) | ||
| Positive | 4 (2.09%) | 7 (4.12%) | 0.26 | 5 (1.29%) | 5 (2.28%) | 0.35 |
| Local recurrence | ||||||
| Negative | 185 (96.08%) | 157 (92.35%) | 384 (98.71%) | 213 (97.26%) | ||
| Positive | 6 (3.92%) | 13 (7.65%) | 0.028 | 5 (1.29%) | 6 (2.74%) | 0.96 |
| Peritoneal dissemination | ||||||
| Negative | 190 (99.48%) | 169 (99.41%) | 386 (99.23%) | 213 (97.26%) | ||
| Positive | 1 (0.52%) | 1 (0.59%) | 0.93 | 3 (0.77%) | 6 (2.74%) | 0.053 |